Overview

Observational Study to Assess a 6-months Treatment With Gladem

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
- Evaluation of a 6-months treatment with Gladem - Experiences with the internet for performing a postmarketing study (PMS) trial
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Sertraline